XORTX Therapeutics Inc. (XRTX)

NASDAQ: XRTX · IEX Real-Time Price · USD

1.762

-0.108 (-5.78%)

At close: Jul 2, 2024, 4:00 PM

1.810

+0.048 (2.73%)

After-hours: Jul 2, 2024, 7:55 PM EDT

XORTX Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	5	5	10	24	-	-
Market Cap Growth	22.42%	-56.01%	-56.89%	-	-	-
Enterprise Value	1	2	3	13	-0	-1
PE Ratio	-	-2.85	-1.86	-19.73	-	-
PB Ratio	2.05	1.32	2.06	2.36	-	-
P/FCF Ratio	-1.86	-0.93	-1.60	-6.49	-	-
P/OCF Ratio	-1.86	-0.93	-1.60	-6.49	-	-
EV/EBITDA Ratio	-1.79	-1.19	-0.52	-10.44	0.14	1.28
EV/EBIT Ratio	-1.73	-1.12	-0.51	-10.35	0.13	1.24
EV/FCF Ratio	-1.15	-0.41	-0.45	-3.39	0.24	2.94
Debt / Equity Ratio	0.01	0.00	0.01	-	-	-0.24
Debt / EBITDA Ratio	0.00	-0.01	-0.01	-	-	-0.09
Debt / FCF Ratio	0.00	0.00	-0.01	-	-	-0.20
Quick Ratio	11.34	11.90	6.96	26.97	0.18	0.62
Current Ratio	13.68	13.80	7.21	28.78	1.99	0.63
Interest Coverage	-	-	-	-353.81	-100.42	-16.70
Return on Equity (ROE)	-64.90%	-31.80%	-71.20%	-21.80%	-246.00%	-
Return on Assets (ROA)	-51.50%	-29.20%	-49.90%	-16.10%	-76.00%	-
Return on Capital (ROIC)	-208.66%	-129.92%	-145.46%	-22.05%	-108.73%	352.75%
Earnings Yield	-65.39%	-35.14%	-53.68%	-5.07%	-	-
FCF Yield	-105.65%	-107.27%	-62.47%	-15.41%	-	-
Buyback Yield / Dilution	-25.91%	-33.91%	-35.25%	-47.77%	-24.34%	-
Total Shareholder Return	-25.91%	-33.91%	-35.25%	-47.77%	-24.34%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).